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Objective: To determine the effectiveness of mindfulness-based stress reduction (MBSR) and mindfulness-based
cognitive therapy (MBCT) on psychological and physical outcomes for people with vascular disease.
Design: Systematic review and meta-analysis of randomised controlled trials.
Data sources: AMED, CINAHL, EMBASE, British Nursing Index, Medline, Web of Science, PsycINFO, Cochrane
Database of Systematic Reviews, Central, Social Sciences Citation Index, Social Policy and Practice, and HMIC
from inception to January 2013.
Review methods: Articles were screened for inclusion independently by two reviewers. Data extraction and
quality appraisal were performed by one reviewer and checked by a second with discrepancies resolved by
discussion with a third if necessary. Random-effects meta-analyses were performed.
Results: Nine articles (from eight original randomised controlled trials) met eligibility criteria and were included
in the ﬁnal review. In total, 578 participants were enrolled across the trials, with participants presenting with
prehypertension/hypertension (n = 3 trials), type 1 or 2 diabetes (n = 2), heart disease (n = 2) and stroke
(n = 1). Meta-analyses, using standardised mean differences, showed evidence of reductions in stress
(−0.36; 95% CI−0.67 to−0.09; p= 0.01), depression (−0.35; 95% CI−0.53 to−0.16; p= 0.003) and anxiety
(−0.50; 95% CI−0.70 to−0.29; p b 0.001). Effects on physical outcomes (blood pressure, albuminuria, stress
hormones) were mixed.
Conclusion: Whilst populations with vascular disease appear to derive a range of psychological beneﬁts from
MBSR/MBCT intervention, the effects on physical parameters of disease are not yet established. More robust
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Vascular disease accounts for over a quarter of all deaths in
westernised countries [1,2]. Moreover, both the disease itself and its
associated clinical events, such as myocardial and cerebral infarction,
are signiﬁcant and distressing life events. Depression, anxiety, and psy-
chological distress, in turn, are independent risk factors for vascular
disease morbidity and mortality [3,4]. In recognition of this, many
guidelines for conditions such as cardiac rehabilitation and hyperten-
sion include stress management as a part of recommended therapy [5,
6]. Equipping patients with skills and coping strategies to help reduce
or manage perceived psychological stress may represent an important
secondary prevention intervention. Although the most effective mode
of stress reduction therapy is yet to be established, increasing recogni-
tion is being given to mindfulness therapy [7].
Mindfulness is deﬁned as the capacity to intentionally be in the
present moment without judgement [8]. Two of the main mindfulness-
based approaches, which aim to cultivate mindfulness therapeutically,
include Mindfulness-Based Stress Reduction (MBSR), and Mindfulness-
Based Cognitive Therapy (MBCT).MBSR is a structured,manualised treat-
ment programme originally developed for the management of chronic
pain and now used widely to reduce psychological morbidity associated
with chronic illnesses and to treat emotional and behavioural disorders
[9]. MBCT, derived from MBSR, was designed for people with a history
of recurrent depression to help prevent future recurrences [10]. The
standard practice for both therapies is a group-based programme held
over 8–10 weeks, with a weekly two hour session, inclusion of daily
homework in the practice of mindfulness and a one day retreat [7].
MBSR and MBCT have been demonstrated to be effective therapies to
treat anxiety and depression, in both clinical and non-clinical populations
[11–13]. A meta-analysis on the effects of MBSR on mental health of
adults with chronic disease showed small but positive effects on depres-
sion anxiety and psychological distress [14]. In addition, MBSR may
also improve physiological aspects of vascular disease [15]. Indeed,
randomised controlled studies of MBSR intervention have been shown
to reduce blood pressure in low-income African-American older adults
[16], and in community dwelling participants with stress related com-
plaints [17].
In vascular disease, pilot and observational studies of MBSR and
MBCT intervention have been associated with improvements in per-
ceived health, quality of life and physiological responses in stroke survi-
vors [18,19], and in reductions of patient reported diabetes-related
distress [20]. MBSR has also been associated with lowered blood pres-
sure and better glycaemic control in patientswith diabetes [21]. Howev-
er, with a predominance in the evidence base of small non-randomised
studies, the efﬁcacy and treatment effects are as yet to be fully under-
stood. The purpose of this systematic review was to establish whetherMBSR and MBCT are effective in the management of both depressive
and physical symptoms in individuals with vascular disease and those
at high risk of vascular disease.Methods
The systematic reviewwas conducted following the general principles
published by the NHS Centre for Reviews and Dissemination [22].
The protocol for this review was developed in consultation with two ex-
perts in MBCT and MBSR (see http://clahrc-peninsula.nihr.ac.uk/
effectiveness-of-mindfulness-based-stress-reduction-and-mindfulness-
based-cognitive-therapy-in-vascu.php). The protocol is registered with
Prospero (registration no. CRD4201300385).Types of studies
Only randomised controlled trials (RCTs) were included.Types of participants
For inclusion, participants had to have vascular disease, which for
the purposes of this review included coronary heart disease, angina,
myocardial infarction, stroke and peripheral vascular disease. People
at a high risk of developing vascular disease including those with diabe-
tes, hypertension and hypercholesterolaemia were also included.Types of interventions
Interventions that were described as either MBSR or MBCT were in-
cluded for review. Shortened versions or amended versions of MBSR/
MBCT interventions were also included, but interventions that were
based on mindfulness but were not speciﬁc programmes of MBSR/
MBCT were excluded.Outcome measures
Both quantitative and qualitative outcomes from RCTs were consid-
ered. Quantitative outcomes of interest were: psychological outcomes
(e.g. anxiety, depression), physical outcomes (e.g. blood pressure,
markers of disease status), measures of health service utilisation and
quality of life. To be eligible for inclusion, studies had to report on either
psychological or physical outcomes (or both). Qualitative outcomes of
interest were views on, and experience of, individuals with vascular
disease receiving MBCT/MBSR.
Table 1
Summary of basic study characteristics
Source, country Study design &
comparator
Participants Vascular condition Intervention Length of Intervention Outcomes
Blom (2012) Canada RCT with waitlist control 101 adults (38 males, 63 females),
mean age of 55 (11) yrs
Stage 1 unmedicated
hypertension
MBSR [The HARMONY Study]:
2.5 h/week with homework of
45 min/day. Included a 1 day retreat
8 weeks Primary: mean awake and 24 h
ambulatory SBP and DBP
de la Fuente (2010) Spain RCT with waitlist control 19 adults (8 males, 11 females),
with mean age of 44 (11) yrs
Stage I or II essential
unmedicated hypertension
MBSR: 90 min/week plus 30
min/day homework
10 weeks Primary: resting SBP and DBP
Hartmann (2012) Germany RCT with TAU control 110 adults (86 males, 24 females),
with age range of 30–70 yrs
Type 2 diabetes (N3 years)
with albuminuria
MBSR [The HEIDIS-Study]: 1/week ,
and a booster session after 6 months
8 weeks
(*plus follow-up at 1 year)
Primary: albuminuria
Secondary: SBP and DBP,
depression, stress, health status
Hughes (2010) USA Pilot RCT with progressive
muscle relaxation control
56 adults (24 males, 32 females)
with mean age of 50 (6) yrs
Unmedicated pre-hypertension MBSR: 2.5 h/week with homework
of 45 min/day
8 weeks Primary: clinic SBP and DBP
Secondary: ambulatory SBP, DBP
Johansson (2012) Sweden RCT with waitlist control 21 adults (9 males, 12 females)
with age range of 30–65 yrs
Stroke N1 year ago with
mental fatigue
MBSR: 2.5 h/week, and home practice of
45 min/day. Included a 1 day retreat
8 weeks Primary: mental fatigue,
anxiety & depression
Secondary: information
processing and attention
Nyklíček (2012) The
Netherlands
RCT with self-help
booklet control
114 adults (88 males, 26 females)
with a mean age of 55 (7) yrs
Heart disease: percutaneous
coronary intervention
MBSR [The MindfulHeart trial]:
2 h/week plus an additional
evaluation session plus
homework of 30 min/day
3 weeks Primary: anxiety, depression,
stress, vitality, QOL
Secondary: mindfulness
Robert McComb (2004) USAa RCT with waitlist control 18 women with a mean
age of 60 (6) yrs
Heart disease: angina/CHF,
hypertension, valve disorders
MBSR: 2 h/week plus additional daily
homework practice
8 weeks Primary: stress hormones,
sub-maximal exercise
response and physical functioning
Tacon (2004) USAa RCT with waitlist control 18 women with a mean
age of 60 (6) yrs
Heart disease: angina/CHF,
hypertension, valve disorders
MBSR: 2 h/week plus additional daily
homework practice
8 weeks Primary: anxiety
Secondary: emotional control,
coping, health locus of control
Van Son (2013) The
Netherlands
RCT with waitlist control 139 adults (70 males, 69 females)
with a mean age 56/57 (13) yrs,
Types 1 & 2 diabetes with low
emotional well-being
MBCT & MBSR fusion [The DiaMind study]:
2 h/week and homework practice for
30 min/day
8 weeks Primary: stress, anxiety &
depression, mood, diabetes distress
Secondary: QoL, HbA1c
MBSR: Mindfulness-based stress reduction.
MBCT: Mindfulness-based cognitive therapy.
a Same study.
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Table 2
Summary of author reported outcomes of MBCT/MBSR interventions
Study Intervention Vascular
condition
Outcome measures & assessment tools Effect on outcomes (data presented for baseline and post intervention only)
Blom (2012) MBSR HT 24 h SBP and DBPa No effect on BP at 8/52
Δ SBP mm Hg (mean, SD) between intervention (INT) and control (C) was 0.0 (±7.2) for SBP, p = 0.96
Δ DBP mm Hg (mean, SD) between INT and CON was 0.4 (±4.7) for DBP, p = 0.60
de la Fuente (2010) MBSR HT Resting SBP and DBPa Signiﬁcant reduction in BP post intervention at 10/52 [and remaining at 4/12].
Δ SBP mm Hg: CON 157.8 (6.8) to 158.5 (6.7), INT 156.4 (7.5) to 129.1 (5.2), p b 0.001
Δ DBP mm Hg: CON 97.4 (3.8) to 98.5 (4.3), INT 97.1 (4.9) to 82.6 (6.3), p b 0.001
Hughes (2010) MBSR HT Resting SBP and DBPa Signiﬁcant reduction in clinic SBP and DBP with intervention compared to PMR at 8/52
Δ SBP mm Hg: PMR 128.8 (6.4) to 128.1 (9.1), INT 130.2 (6.3) to 125.3 (7.4), p = 0.02
Δ DBP mm Hg: PMR 78.5 (6.1) to 79.5 (7.9), INT 77.3 (4.8) to 75.4 (5.1), p b 0.01
Hartmann (2012) MBSR DM Albuminuria, HbA1c & 24 h SBP and DBPa
Stress and depression (Patient Health Questionnaire)
Subjective health (SF-12)
No effect on any outcome at 8/52. (At 1 yr, signiﬁcant reduction in DBP, depression & perceived mental health status)
Δ albuminuria (median mg/24 h): CON 45.0 to 66.5, INT 59.6 to 42.8, p = 0.42
Δ HbA1c % (mean, SE):CON 7.3 (0.1) to 7.1 (0.1), INT 7.3 (0.1) to 7.2 (0.1), p = 0.70
Δ SBP mm Hg (mean, SD):CON 139.1 (14.3) to 140.8 (15.0), INT 142.3 (18.2) to137.6 (14.4) p = 0.27
Δ DBP mm Hg (mean, SD):CON 80.0 (7.5) to 80.7 (8.6), INT 80.5 (8.0) to 77.7 (7.9), p = 0.06
Johansson (2012) MBSR S Mental fatigue (MFS)a
Anxiety and depression (CPRS)a
Information processing and attention
No signiﬁcant effects of intervention at 8/52. Signiﬁcant improvements in cognitive tests for intervention but not controls.
Δmental fatigue: CON no change, INT reduction p = 0.06
Δ anxiety and depression: NS
Δ trail making test: INT faster than CON, p = 0.01
Nyklíček (2012) MBSR HD Anxiety & depression (SAD-4)a
Stress (Perceived Stress Scale)a
Vitality (GMS), QOL (WHO)
No signiﬁcant effects (author adjusted for age, education and comorbidity) on stress and anxiety & depression at 4/52. No
effects on
vitality. Signiﬁcant effects of psychological QOL, but not physical QOL. Mindfulness increased in intervention only
Δ stress: CON 20.4 (0.9) to 18.4 (1.1), INT 22.9 (0.9) to 18.4 (1.1) p N0.10
Δ anxiety & depression: CON 3.01 (0.49) to 2.80 (0.42), INT 4.03 (0.49) to 2.42 (0.41) p = 0.072
Robert McComb (2004)
b
MBSR HD Resting stress hormones (cortisol and catecholamines—
standardised methods), physical functioning (SF-36)
No signiﬁcant main effects or interaction for resting stress hormones or physical function.
Δ catecholamines: CON 598 (434) to 576 (329), INT 523 (164) to 484 (204), NS
Δ cortisol: CON 21.0 (5.6) to 21.2 (6.4), INT 19.7 (7.9) to 15.8 (7.3), NS
Δ physical functioning: CON 38.3 (11.6) to 35.3 (9.8), INT 40.6 (13.7) to 42.1 (14.1), NS
Tacon (2004)b MBSR HD Anxiety (STAI), emotional control (CECS),
coping (PRSOC),
Signiﬁcant effects observed for anxiety, emotional control and coping.
Δ anxiety: CON 43.2 (12.3) to 43.5 (13.3), INT 37.9 (10.9) to 29.1 (7.4), p b 0.01
Δ suppress emotion: CON 53.7 (4.5) to 55.5 (6.0), INT 62.1 (4.9) to 57.4 (5.0), p b 0.02
Δ coping: CON 14.1 (5.3) to 16.2 (3.9), INT 15.3 (2.3) to 13.8 (1.8), p b 0.03
Van Son (2013) MBCT &MBSR DM Stress (Perceived Stress Scale)a
Anxiety (HADS)a
Depression (HADS)a
Intervention resulted in sig reduction in stress, depressive symptoms and anxiety at 8/52
Δ stress: CON 20.5 (5.59) to 19.6 (6.7), INT 19.5 (6.0) to 14.2 (6.9), p b 0.001
Δ anxiety: CON 9.2 (3.6) to 8.7 (4.1), INT 8.4 (3.3) to 6.3 (3.5), p = 0.02
Δ depression: CON 8.9 (3.9) to 8.5 (4.7), INT 7.9 (3.8) to 5.4 (4.1), p b 0.01
NS: not signiﬁcant (no data presented).
DM: diabetes.
HT: hypertension.
HD: heart disease.
S: stroke.
a Primary outcome measure.
b Same study.
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Fig. 1. Search strategy (example shown for Medline).
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The search strategy was developed by an information specialist in
consultationwith topic andmethod experts. The strategy used a combi-
nation of MeSH terms and free text terms. An illustration of the search
strategy used on MEDLINE can be seen in Fig. 1. Eleven databases
were searched from inception to January 2013: AMED, CINAHL, Embase,
British Nursing Index, MEDLINE, Web of Science, PsycINFO, Cochrane
Database of Systematic Reviews, Central, Social Policy and Practice,
and HMIC. No date or language restrictions were used. No date or lan-
guage restrictions were used. Hand searching of key journals (Journal
of Psychosomatic Research, and Psychosomatic Medicine), identiﬁed
as prominent in the search and the bibliographies of included studies,was also done for relevant articles. Searching of grey literature was
also undertaken on the websites http://mindfulnessteachersuk.org.uk
and http://www.mindfulexperience.org/. Forward and backward cita-
tion chasing of each included article was conducted. Two reviewers
(RA, RW or AB) independently screened titles, abstracts and full texts
using the eligibility criteria. Discrepancies were discussed and resolved
by a third reviewer (RW or AB) where necessary.
Risk of bias and study quality
The methodological quality of each paper was assessed using the
Cochrane ‘risk of bias’ tool [23]. The tool includes six key criteria against
which potential risk of bias is judged: adequacy of allocation sequence
346 R.A. Abbott et al. / Journal of Psychosomatic Research 76 (2014) 341–351generation; adequacy of allocation concealment; blinding of partici-
pants, personnel or outcome assessors; completeness of outcome
data; selectivity of outcome reporting, and other biases. In addition to
the Cochrane risk of bias tool, four additional aspects of quality relating
to reporting of eligibility criteria, similarity of baseline characteristics,
compliance with intervention and data collection tool validity were
assessed. Quality was assessed by one reviewer (RA, AB, or RW), with
judgements checked by a second (RW, RA, or AB). Any discrepancies
were discussed and resolved.
Data collection
Data on the study design, the setting, the population, the interven-
tion, the outcomes and results, and risk of bias were collected using a
standardised, piloted data extraction form. Data were extracted by one
of two reviewers (RA, AB) and fully checked by another (RA or RW).
As we were interested in any modiﬁcations made to the standard
MBSR or MBCT intervention, to assess whether modiﬁcations impacted
on effects, authors of included studies were also contacted for informa-
tion with a request for the manuals supporting their intervention.
Data analysis and synthesis
Random effect meta-analyses were performed where we had sufﬁ-
cient data from RCTs assessing the same clinical outcome. Authors of
included studies were contacted to provide additional data where re-
quired, this included group mean and standard deviations, correlations
and, in one case, raw data. Follow-up timewas consistent across almost
all studies, eight weeks for all except one (ten weeks). Pooling was per-
formed on the outcomesmeasured immediately following the interven-
tion (only two studies had additional longer term assessment). As we
used a random-effects model for the meta-analyses, the weightings
for each study were determined not only by the size of each study in-
cluded, but also by between-study heterogeneity. All studies analysed
change in outcome between baseline and follow-up. Unadjusted sum-
mary data were used to calculate standardised mean differences
(SMDs). We calculated the mean change in each group based on mean
differences between baseline and follow-up and the standard deviation
was pooled across the treatment and control groups, taking correlation
between baseline and follow-up into account. As all the outcomes were
continuous, pooled effects are reported as standardised mean differ-
ences with 95% conﬁdence intervals. Where there were differences in
the number of individuals contributing to baseline and follow-up
summary statistics we used the average sample size. Where the mean
change from baseline, standard deviation (SD) and sample size for
each trial arm were reported in the papers we used the t-test to calcu-
late the mean difference between arms and standard error. In the
meta-analysis for blood pressure, in which themean and SD at baseline
and follow-up were reported for each group and raw data were not
available, correlations between baseline and follow-up from a compara-
ble study [24] (SBPmeasurement correlations 0.73 and 0.75, DBP corre-
lations 0.77 and 0.77, for treatment and control groups respectively)
were used to help calculate the standard error. For another study [25]
in the meta-analysis for anxiety, post intervention values only were
used, as within study or comparable study correlation data for the
State-Trait Anxiety Inventory (STAI) outcome measure were not avail-
able. Another study [26] reported assessing anxiety and depression
using two complementary instruments: the Hospital Anxiety and
Depression Scale (HADS) and the Proﬁle of Mood States (POMS). We
did not combine the HADS and POMS effect sizes as the correlation be-
tween the two measures was not known [27] (requested from author
but not provided). HADS was therefore used for the meta-analyses
(the authors citing this as themorewidely used andwell known instru-
ment), and sensitivity analyses were performed to assess the effect on
the pooled effect with inclusion of POMS instead of HADS.Heterogeneity across estimates was quantiﬁed using the I-squared
statistic and the p-value for the Q-test was used to test for evidence of
heterogeneity [28]. Data analysis was carried out using Stata [Stata
Corporation. Stata Statistical Software. Release 12.1. College Station,TX,
2011] and Review Manager (RevMan) Version 5.2 software (http://
ims.cochrane.org/revman). Synthesised results are presented by out-
come type. Effect sizes are expressed as small (0.2–0.5), moderate
(0.5–0.8) and large (N0.8) [29]. Where pooling was not appropriate or
possible, the ﬁndings have been summarised in narrative form.
Results
The electronic searches found a total of 1280 results, and after title and abstract
screening, 55 full texts were retrieved for closer examination. A total of nine articles
(from eight original randomised controlled trials) were included in the ﬁnal review,
with two identiﬁed from forward and backward citation chasing (none were identiﬁed
from hand searching of key journals). Reasons for exclusion at the full text stage can be
seen in Fig. 2.
Study characteristics
The nine articles (from eight trials) that met inclusion criteria were published from
2004 onwards, with ﬁve published in the past year alone (2012/2013) (see Table 1).
The eight trials were conducted in Canada, Germany, Spain, Sweden, The Netherlands
(n= 2) and the United States of America (n= 2). Trial size ranged from 18 to 139 partic-
ipants, with four of the eight trials having N100 participants [26,30–32]. In total, 578
participants were enrolled across the eight trials. Participants were those presenting
with prehypertension or hypertension (n = 3 trails), type 1 or 2 diabetes (n = 2), heart
disease (n = 2) and stroke (n = 1). Five trials employed a wait-list control design, two
an active control design with either provision of a self-help booklet or attendance at
progressive muscle relaxation classes, and one a standard control arm offering treatment
as usual. The mean age of participants recruited ranged from 44 to 60 years, and all bar
one trial [25,23] (100% female) was mixed sex, with the percentage of females ranging
from 22 to 62%. In six out of the eight trials, there was no prerequisite for participants to
present with any psychopathology prior to randomisation; eligibility was based on phys-
ical condition alone [24,25,30–34]. In one trial [26], participants were eligible for recruit-
ment only from outpatient diabetes clinics if they had a low level of emotional well-
being (scored b13 on theWHO-5well being index), and in another [35], participants had
a co-morbidity of mental fatigue.
Intervention characteristics
The frequency and dose of intervention time for the participants was clearly reported
for seven of the eight trials. There was little variation amongst the interventions: all were
group based, and groupsmet once aweek for a range of 1.5–2.5 h/week, with the addition
of daily homework for 30-45min for six days perweek (reported for seven out of the eight
trials). Most trials involved eight weeks of intervention (n = 6), with one trial reporting
ten weeks [34], and one trial evaluating a shortened version of three weeks [32]. Three
trials reportedmaking adaptations to the standard programme: two involving outpatients
with diabetes [26,31] that included education and practices for difﬁcult thoughts and feel-
ings related speciﬁcally to diabetes, and one for stroke patients [35] that allowed extra
time to pause and reﬂect. Only two manuals were received from initial requests, with
two other authors reporting no change to standard intervention, other than that already
reported in the manuscript. Only two [30,35] of the eight trials included the provision of
a one day retreat (typically considered to be part of the standard MBSR programme) in
addition to the weekly classes. Seven trials [24,25,30–35] were MBSR interventions, and
one, the DiaMind study [26], was a fusion of MBCT and MBSR therapy.
Outcomes
Five of the studies reported physical primary outcomes: blood pressure [24,30,35],
albuminuria [31] and stress hormone levels [33] - see Table 2 The remaining four studies
reported psychological primary outcomes: anxiety and depression and/or stress [25,26,
31] andmental fatigue [35]. Only two studies reported on both psychological and physical
outcomes [26,31]. Secondary outcomes varied according to clinical population and trial
objective, comprising predominantly a variety of disease status markers (diastolic blood
pressure (DBP), systolic blood pressure (SBP), glycosylated haemoglobin (HbA1c)) and
psychological and physical health outcomes (anxiety and depression, perceived stress,
emotional well-being, coping, and health-related quality of life). No trials reported quali-
tative outcomes.
Study quality (risk of bias)
A summary of the risk of bias is presented in Fig. 3. Despite all being described
as randomised controlled trials, for the majority of the studies, the methods of
randomisation, particularly how the random sequence was generated, were unclear. Fur-
thermore,whilst eligibility criteriawere describedwell, only one study reportedparticipa-
tion rates of thosewhowere deemedeligible, raising the possibility of selection bias across
Studies identified from electronic searches
from inception to January 2013 (n = 1280)
Citations excluded by initial screening of title and 
abstracts (n = 1225)
Potentially relevant articles ordered for detailed full text screening (n = 55)
Articles excluded after full text review with reasons (n = 48)
Not a randomised controlled study (n = 21)
Review atricle (n = 10)
Not a population with vascular disease (n = 7)
Not MBSR or MBCT (n = 6)
Text not retrievable (n= 3)
Full text articles reviewed and meeting inclusion criteria (n = 7). 
Articles checked for both forward and backward citations.
Final articles for inclusion in systematic review (n = 9 )
Articles meeting inclusion criteria from backward citation 
chasing (n = 0)
Articles meeting inclusion criteria from forward citation 
chasing (n = 2)
Fig. 2. Flow chart of search results and article retrieval.
347R.A. Abbott et al. / Journal of Psychosomatic Research 76 (2014) 341–351the studies. Due to the nature of this type of intervention, all of the studieswere also at risk
of bias with participants clearly aware of their group allocation.
For most of the studies, outcome data were complete or missing data were accounted
for adequately, and data collection tools were deemed valid and reliable. However, com-
pliance with the intervention was reported in only two of the eight trials, with drop-out
rates ranging from 5% to 26% across the studies. For themajority of the studies insufﬁcient
information was provided to evaluate the blinding of assessors; only one study explicitly
reported that assessors were blinded to group assignment.
Synthesis by outcome
Psychological
Overall, MBSR/MBCT participation resulted in signiﬁcant favourable small to moderate
effects for psychological outcomes across a variety of clinical populations. Using un-
adjusted data, small but signiﬁcant, beneﬁcial effects on stress (SMD−0.38, 95% CI−0.67
to −0.09, p = 0.01) and depression (SMD −0.35, 95% CI −0.53 to −0.16, p b 0.001)
were observed across three (n = 363) and four trials (n = 384) respectively (see forest
plots in Figs. 4 and 5). These effects were observed in people with diabetes (the DiaMIND
study and the HEIDIS study) [26,31], with heart disease who had undergone coronary
perfusion (theMindfulHEART study) [32] andpeoplewhohadbeen suffering frompatholog-
ical mental fatigue for one year post stroke (included in the depression analysis only) [35].
Assessment of stress was derived from the Perceived Stress Scale [26,32] and the Patient
Health Questionnaire (PHQ) [31]. Assessment of depression was derived from the PHQ[31], the HADS [26], the Symptoms of Anxiety and Depression index (SAD-4) [32] and the
Comprehensive Psychopathological Rating Scale (CPRS) [35]. Sensitivity analyses using the
‘depression-dejection’ outcome from POMS instead of the HADS depression scores for the
DiaMIND study showed no difference in the overall effect in the meta-analysis reported
above; SMD−0.36, 95% CI−0.56 to−0.16, p b 0.001.
Using the unadjusted data for ourmeta-analysis, the effects onboth stress and depres-
sion appear evident even in the brief version of the MBSR MindfulHEART intervention.
However, when the authors of this shortened intervention fully adjusted their data for
baseline values, age, education and comorbidity, the effects were only signiﬁcant for
those b60 yrs of age [32].
A signiﬁcant moderate effect was also observed for anxiety (SMD−0.50, 95 %CI−0.70
to−0.29, p b 0.001), as shown in Fig. 6. This effect was observed across four studies
(n = 269) in peoplewith heart disease [25,33], diabetes [26] and those recovering from a
stroke [35]. Anxiety was assessed with a different tool in each study; HADS, SAD-4, CPRS,
and the State-Trait Anxiety Inventory (STAI). Again, sensitivity analyses using the
‘anxiety-tension’ outcome fromPOMS instead of theHADS anxiety scores for theDiaMIND
study showed little difference in the overall effect in the meta-analysis reported above;
SMD−0.55, 95% CI−0.75 to−0.36, p b 0.001.
All ﬁve studies included in the analyses on the primary psychological outcomes also
reported signiﬁcant improvements in a variety of measures of well-being and quality of
life. In the DIAMIND study [26], signiﬁcant beneﬁcial effects were observed immediately
after intervention for both self-reported mental and physical quality of life (SF12), but
not for disease-speciﬁc distress (measured with the Problem Areas in Diabetes Survey),
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348 R.A. Abbott et al. / Journal of Psychosomatic Research 76 (2014) 341–351which was attributed to low levels at the start of the trial. The MindfulHEART study [32]
observed improvements in self-reported psychological and social quality of life (Seattle
Angina Questionnaire) respectively, but no effect on physical quality of life. Whilst the
HEIDIS study [31] found no change in self-reported mental or physical quality of life
(using the SF-12) post intervention, at one year post intervention, signiﬁcant effects
were observed for perceived mental quality of life. Tacon et al. [25] also reported signiﬁ-
cant improvements in emotional control and coping in females with heart disease, though
in the same group there was no effect on the participants' perception of their health locus
of control.Fig. 4. Forest plot showing effecPhysical
Four RCTs assessed the effects of MBSR intervention on systolic blood pressure (SBP)
and diastolic blood pressure (DBP) in participants with unmedicated prehypertension
(SBP 120–139 mm Hg or DBP 80–89 mm HG) [24], unmedicated grade 1 hypertension
(24 h SBP N130 mm Hg or 24 h DBP N 80 mm HG) [30], a mixture of unmedicated grade
1 (140–159 mm Hg SBP, 90–99 mm Hg DBP) and 2 (160–179 mm Hg SBP, 100–
109 mm Hg DBP) hypertension [34] and a group at high risk of diabetes complications
[31]. Two of the trials employed a waiting list control [30,34], one used an active control
programme of progressive muscle relaxation (PMR) [24] and one treatment as usualts of MBSR/MBCT on stress.
Fig. 5. Forest plot showing effects of MBSR/MBCT on depression.
349R.A. Abbott et al. / Journal of Psychosomatic Research 76 (2014) 341–351[31]. The pooled results indicate signiﬁcantmoderate effects of MBSR for SBP, SMD−0.78
(95% CI−1.46 to−0.09, p = 0.03), and DBP, SMD−0.67 (95% CI−1.26 to−0.08,
p = 0.03). The results for SBP are shown in Fig. 7, with DBP following an almost identical
pattern (not shown).
Heterogeneity (I2 = 89%) was high for both analyses, and observation of the forest
plots show the study by de la Fuente et al. [34] reported markedly different effects from
the other three studies. Of the four, de la Fuente et al. had the smallest sample size
(n= 17) and the study population also had higher SBP and DBP at baseline (including
those with both grades 1 and 2 hypertension). This may partly explain the greater effect
size observed, though it could also be attributable to some other aspect of the intervention
or intervention delivery. A repeat of the meta-analysis without inclusion of this study
reduced thepooled effect size (as expected) and the effect,whilst still favouring intervention,
was no longer signiﬁcant for either SBP or DBP (SMDs−0.31, 95% CI−0.64 to 0.01, p=0.06
and−0.29, 95 %CI−0.64 to 0.06, p = 0.11 respectively).
Other physical outcomes relate tomeasures of disease status/progression. The HEIDIS
Study [31] is a large (n = 110) ongoing ﬁve year study assessing the effects of MBSR on
outpatients with type 2 diabetes with microalbuminuria or albuminuria compared to
treatment as usual. No signiﬁcant effects of intervention were observed for the primary
outcome measure of albuminuria, or secondary outcome measure of HbA1c at post-
intervention, or at the one year follow-up. The DiaMind study [26] observed no effect of
intervention on HbA1c immediately post intervention and Robert McComb et al. [33],
found no effect of intervention on resting stress hormone levels or physical functioning
for women with heart disease.
Discussion
This is the ﬁrst systematic review and meta-analysis of mindfulness
based therapy intervention for people with, or at risk of, vascular dis-
ease. Nine articles (eight RCTs), examiningMBSR orMBCT interventions
were included, and the effects on psychosocial and/or physical out-
comes were assessed. The review conﬁrms the ﬁndings from other
systematic reviews in populations with somatic diseases and chronic
pain, that mindfulness therapy appears effective for assisting with
depression, anxiety and psychosocial stress [11,14]. Small to moderate
beneﬁcial effects were observed for stress (−0.36; 95% CI −0.67
to −0.09; p = 0.01), depression (−0.35; 95% CI −0.53 to −0.16;
p = 0.003) and anxiety (−0.50; 95% CI−0.70 to−0.29; p b 0.001).
These effect sizes are comparable with previous ﬁndings; SMDs of
0.53 for combined mental health outcomes across healthy and clinical
populations [36] and 0.32–0.47 for anxiety, distress and depression in
populations with chronic medical disease [14]. Since only two of the
studies recruited participants based on pre-intervention mood states
(low emotional well being [26] and mental fatigue [35]), it is plausible
that this is an underestimation of the possible effects of MBSR and
MBCT intervention for a population that is known to be at increased
risk of psychosocial distress [3]. The evidence for the ability of MBSRFig. 6. Forest plot showing effectand MBCT intervention to result in favourable physical outcomes was
less clear: meta-analyses of four studies showing a small but limited
effect on blood pressure for individualswith hypertension and diabetes,
and two individual studies found no effect on markers of diabetes pro-
gression. These results are similar to ﬁndings from comparable meta-
analyses in other clinical populations: Rainforth et al. [37] reported little
evidence of effectiveness of stress-based therapies for those with high
blood pressure, and Markowitz et al. [38] found one-to-one cognitive
based therapy effective in improving depression but not markers of
disease status in patients with diabetes with co-morbid depression.
Whilst the ﬁndings from this review are favourable for MBSR and
MBCT intervention for vascular populations with regard to improving
psychosocial health, a few caveats need to be considered. The majority
of studies in this review employed a wait-list control which can lead
to differences in expectancy effects, resulting in an overestimation of
the treatment effect. That said, the use of an active control treatment
(PMR) [24] resulted in a greater treatment effect than await-list control
[30] in trials of patients with grade 1 hypertension. Use of a wait-list
control also limits the generalisability of the ﬁndings to those who are
agreeable to waiting per se. This was reﬂected in the low proportion
of eligible people who agreed to participate in some studies [26], a
number which was not always reported. Indeed, the potential bias of
self-selection in this type of study design has been recognised previous-
ly [12,14,39]. There was also considerable drop-out in some of the in-
cluded trials amongst the intervention groups. Whether tailoring the
MBSR and MBCT interventions to better suit the speciﬁc needs of the
clinical population would help reduce the drop-out rate is not known.
Few studies reported long term follow-up and thismay be an impor-
tant factor to consider for effects on physical outcomes. In the study by
Hartmann et al. [31], signiﬁcant beneﬁcial psychosocial and physical
effects for patients with diabetes were observed only one year after
the MBSR intervention, but not immediately post intervention. The
Hartmann et al. [31] study plans to follow up at 5 years, and the Van
Son et al. [26] study plans to follow up at 6 months (only immediate
post intervention results are publicly available so far), but the other
studies reported no long term follow up. Lack of planned long term fol-
low up for studies assessing mindfulness therapies has been noted by
others [15]. Another potential reason for ﬁnding little effect of interven-
tion on physical outcomes may be the normality, or marginally at-risk
level, of some of the outcome measures at baseline. The meta-analyses
on the hypertension studies within this review showed that interven-
tion beneﬁtedmost those with highest baseline blood pressures. Whilsts of MBSR/MBCT on anxiety.
Fig. 7. Forest plot showing effects of MBSR/MBCT on hypertension.
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attributable to some other aspect of the population or a speciﬁc compo-
nent of the intervention or its delivery, it may also have simply reﬂected
a regression to the mean effect i.e. that the intervention works best for
those farthest away from the mean/normal values. Indeed studies that
reported outcome measures at baseline that approached normality,
such as diabetes distress [26] and stress hormones [33], found no effect
of the intervention on those measures. It was also interesting to note
that whilst Hartman et al. [31], as noted earlier, observed no effects of
intervention ondepression inpatientswithdiabetes immediately post in-
tervention, which they attributed to the low presence of depression at
baseline, they did observe beneﬁts a year later. They attributed this to
the MBSR intervention preventing progression into depression,
suggesting that the effects of intervention accumulate with time.
This supports the need for longer term assessments of mindfulness
therapy interventions.
With only two trials reporting the degree of compliance with the
intervention to either the weekly class attendance or degree of home
practice, it was not possible to explore the impact of dose of interven-
tion on outcomes. Nor was it possible in this review to address the
mechanism of intervention.MBSR andMBCT are complex interventions
and patients may beneﬁt through one of several different mechanisms,
for examplemindfulmovement (yoga), increased physical activity gener-
ally, or greater self-compassion. Indeed the amount ofmindfulwalking or
mindful yoga engagement, reported in some of the studies [26,30], is
likely to have varied across the interventions, and this could impact out-
comes. Although the precise mechanism of action of mindfulness thera-
pies is not known, increased mindfulness has been proposed to mediate
improvement in functioning by reducing rumination and emotional
avoidance and improving behavioural self-regulation [15]. However,
mindfulness was assessed in only one [32] out of the eight RCTs. In this
study, changes in mindfulness fully mediated the differences between
controls and intervention regarding symptoms of anxiety, depression
and quality of life. There is clearly a need for future studies to assess
and report both on compliance and on mindfulness itself to help under-
stand the critical attributes of mindfulness intervention.
Strengths and limitations
This is the ﬁrst systematic review and meta-analysis of mindfulness
based therapies for populations with, or at risk of, vascular disease. The
review followed best practice guidelines for systematic reviews [22] and
did not restrict by date or language, nor by whether studies had been
published or not. Authors of papers who had published abstracts only,
were contacted for their data, if available. In addition, authors were
contacted for additional data to optimise our approach to meta-
analysis (with ﬁve out of six authors assisting with this request).
The limitations mainly relate to study quality. In general, the
reporting of the studies, especially with regard to compliance with the
intervention, and detailed information on the components of the inter-
vention was lacking. Furthermore, whilst in this type of study it is im-
possible to blind the participants with regard to treatment, there was
poor reporting of whether there was blinding of outcome measures.
Any exploration of whether speciﬁc attributes or dose of the interventionimpacted oneffectivenesswere also preventedby lack of detailwithin the
papers, along with a poor response to the request for manuals (though
three authors did reportmaking only small changes to the standard inter-
vention approach already documentedwithin themanuscripts). It should
also be noted thatwewere limited to a relatively small number of studies
for each of the outcome meta-analyses.
Implications for practice and research
Vascular disease is a leading cause of morbidity andmortality. There
is a recognised need to equip patients with vascular disease with skills
and coping strategies to help reduce ormanage perceived psychological
stress in the long-term and mindfulness-based approaches have been
advocated as one promising psychosocial approach. This systematic re-
view demonstrated that structured group-based mindfulness based in-
terventions such asMBSR andMBCTmay be beneﬁcial in practice across
a range of psychological and psychosocial issues encountered by indi-
viduals with vascular disease. Of note, was the fact that mindfulness in-
tervention appeared to be effective despite the relatively low levels of
baseline depression, anxiety and stress. This suggests that mindfulness
may be of beneﬁt to the perceived psychological health and emotional
well-being of vascular disease populations with a broad spectrum of
mood states not just those showing signs of distress. There is also
scope that such interventions may also be of beneﬁt to physiological
functioning, though the short term studies to date do not support this.
Future RCTs of MBSR and MBCT need to make provision for long term
follow up to establish whether the beneﬁts of intervention do accumu-
late with time as has been suggested.
It is unclear from the available studies what the time course of
change in physical outcomes is and how they may compare with phar-
macotherapy and more conventional behaviour change strategies.
Future studies should consider the time course of change in physical
and mental outcomes with mindfulness intervention. There also needs
to be careful consideration given to the choice of the control group
employed, preferably providing an active control group to minimise
the potential bias of observed effects. Tailoring the intervention to suit
the needs of the clinical population warrants further investigation.
Conclusions
Whilst populationswith vascular disease appear to derive a range of
psychological beneﬁts from MBSR/MBCT intervention, their ability to
impact on the physical parameters of disease is yet to be conﬁrmed.
More robust studies, with longer term follow-up, are required to estab-
lish full efﬁcacy of such intervention.
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